ENGLISH

Hypercalcemia of Malignancy

By J. Pfeilschifter (auth.) , Prof. Dr. F. Raue (eds.)

Book information

Publisher
Springer-Verlag Berlin Heidelberg
Year
1994
ISBN
978-3-642-85075-2, 978-3-642-85073-8
DOI
10.1007/978-3-642-85073-8
Language
english
Format
PDF
Filesize
9 MB (9227175 bytes)
Series
Recent Results in Cancer Research 137
Edition
1
Pages
163\169
Time added
2013-12-12 02:00:00
Oncology

Description

Hypercalcemia is the most common life-threatening metabolic disorder associated with cancer. The pathophysiological, epidemiological and clinical aspects of hypercalcemia of malignancy are presented in this issue, with a focus on the recently discovered humoral factor responsible for the development of hypercalcemia. With a better understanding of the pathophysiology of this condition and the development of new potent drugs, capable of inhibiting bone resorption, especially bisphosphonates, the clinician will be more successful in correcting hypercalcemia in the great majority of patients.

Similar books